"SOFI Center for Esophageal Wellness specializes in the diagnosis and surgical treatment of patients with foregut disorders. Foregut refers to of the upper portion of the GI tract – the esophagus and stomach. The most common disease of the foregut is GastroEsophageal Reflux Disease (GERD); however many other entities such as LaryngoPharyngeal Reflux (LPR), achalasia, gastroparesis, and esophageal and gastric cancer are also disorders of the foregut."

During the past decade, Institute of Esophageal and Reflux Surgery conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Esophageal and Reflux Surgery" #1 sponsor was "EndoStim Inc." with 1 trials, followed by "Ethicon Endo-Surgery" with 1 trials sponsored, "Foregut Research Foundation" with 1 trials sponsored, "Mayo Clinic" with 1 trials sponsored and "The Heartburn Foundation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Esophageal and Reflux Surgery" #1 collaborator was "EndoGastric Solutions" with 1 trials as a collaborator, "Fox Valley Surgical Associates" with 1 trials as a collaborator, "Institute of Esophageal and Reflux Surgery" with 1 trials as a collaborator, "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator and "University of California, Irvine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Esophageal and Reflux Surgery" are "Hiatal Hernia" (3 trials), "GERD" (2 trials), "Gastroesophageal Reflux" (2 trials), "Gastroesophageal Reflux Disease" (2 trials) and "Reflux, Gastroesophageal" (2 trials). Many other conditions were trialed in "Institute of Esophageal and Reflux Surgery" in a lesser frequency.

Most popular intervention types in "Institute of Esophageal and Reflux Surgery" are "Device" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "LINX Reflux Management System" (2 trials), "EndoStim stimulation for first six months of study" (1 trials), "EndoStim stimulation from Month 6 thru end of study" (1 trials), "Fundoplication" (1 trials) and "LAPAROSCOPIC PARAESOPHAGEAL HIATAL HERNIA REPAIR COMBINED WITH TRANSORAL INCISIONLESS FUNDOPLICATION" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Esophageal and Reflux Surgery" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Esophageal and Reflux Surgery". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institute of Esophageal and Reflux Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Esophageal and Reflux Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".